Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 3320507)

Published in Emerg Infect Dis on August 01, 2005

Authors

Conan MacDougall1, Spencer E Harpe, J Patrick Powell, Christopher K Johnson, Michael B Edmond, Ron E Polk

Author Affiliations

1: Virginia Commonwealth University School of Pharmacy, Richmond, Virginia 23298-0533, USA.

Articles cited by this

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis (2001) 9.59

Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis (2001) 4.50

Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis (1984) 4.42

Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis (2005) 3.97

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother (1999) 3.16

Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis (2002) 3.07

The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med (2002) 2.97

Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother (2002) 2.16

Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis (2003) 2.06

Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis (2001) 1.92

Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis (2003) 1.72

Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin Infect Dis (2002) 1.68

Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents (2000) 1.33

Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol (1999) 1.31

Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis (2004) 1.25

Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother (2000) 1.23

Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis (2001) 1.22

Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect (2000) 1.21

Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. J Antimicrob Chemother (2001) 1.17

Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clin Microbiol Infect (2001) 1.15

Epidemiological interpretation of antibiotic resistance studies - what are we missing? Nat Rev Microbiol (2004) 1.13

Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis (2004) 1.12

Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin. Antimicrob Agents Chemother (2001) 1.09

Effect of duplicate isolates of methicillin-susceptible and methicillin-resistant Staphylococcus aureus on antibiogram data. J Clin Microbiol (2003) 1.02

Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes. Clin Infect Dis (1999) 0.98

Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002. Int J Antimicrob Agents (2004) 0.97

Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals. Am J Health Syst Pharm (2003) 0.95

Articles by these authors

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis (2004) 20.99

Antibiotic prevention of acute exacerbations of COPD. N Engl J Med (2012) 4.11

Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis (2003) 3.53

Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev (2005) 3.27

Managing SARS amidst uncertainty. N Engl J Med (2003) 2.87

Screening inpatients for MRSA--case closed. N Engl J Med (2013) 2.44

Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol (2008) 2.27

Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J (2003) 2.22

Potentially inappropriate medication use is associated with clinical outcomes in critically ill elderly patients with neurological injury. Neurocrit Care (2014) 2.04

Positive deviance: a new strategy for improving hand hygiene compliance. Infect Control Hosp Epidemiol (2010) 1.64

Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. J Infect (2011) 1.61

Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study. Pacing Clin Electrophysiol (2014) 1.60

Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol (2011) 1.54

Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis (2005) 1.54

Infections associated with religious rituals. Int J Infect Dis (2013) 1.44

Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. J Infect (2005) 1.43

Patient-to-patient transmission of hepatitis C virus. Ann Intern Med (2005) 1.40

Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting. PLoS One (2011) 1.35

Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect Dis (2006) 1.31

Septic shock--evaluating another failed treatment. N Engl J Med (2012) 1.30

A pharmacoepidemiologic analysis of the impact of calendar packaging on adherence to self-administered medications for long-term use. Clin Ther (2011) 1.30

Resistant gram-negative bacilli: A neglected healthcare crisis? Am J Health Syst Pharm (2007) 1.24

Balancing the benefits and risks of blood transfusions in patients undergoing cardiac surgery: a propensity-matched analysis. Interact Cardiovasc Thorac Surg (2013) 1.22

Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis (2007) 1.22

Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis (2007) 1.17

Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis (2013) 1.17

Successful prevention of ventilator-associated pneumonia in an intensive care setting. Am J Infect Control (2009) 1.16

Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis (2004) 1.12

Improving the safety of medication administration using an interactive CD-ROM program. Am J Health Syst Pharm (2006) 1.11

Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature. Clin Infect Dis (2005) 1.11

Measuring rates of hand hygiene adherence in the intensive care setting: a comparative study of direct observation, product usage, and electronic counting devices. Infect Control Hosp Epidemiol (2010) 1.11

Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol (2007) 1.10

Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti Infect Ther (2012) 1.10

Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother (2006) 1.08

Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr (2007) 1.08

Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era. Am J Infect Control (2010) 1.06

Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection. J Clin Microbiol (2006) 1.06

Post-malaria neurological syndrome: a case report and review of the literature. J Travel Med (2009) 1.05

A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting. BMC Infect Dis (2012) 1.02

A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms. Am J Infect Control (2007) 1.02

Diversity of antimicrobial use and resistance in 42 hospitals in the United States. Pharmacotherapy (2008) 1.01

Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci. BMC Infect Dis (2006) 1.01

Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control. Int J Antimicrob Agents (2007) 0.98

Blood transfusion in cardiac surgery does increase the risk of 5-year mortality: results from a contemporary series of 1714 propensity-matched patients. Transfusion (2013) 0.98

Team-based prevention of catheter-related infections. N Engl J Med (2006) 0.96

Positive deviance: a program for sustained improvement in hand hygiene compliance. Am J Infect Control (2011) 0.95

Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers. Pharmacotherapy (2011) 0.94

A multicenter study using positive deviance for improving hand hygiene compliance. Am J Infect Control (2013) 0.92

Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. BMC Infect Dis (2006) 0.92

Fluoroquinolone use and fluoroquinolone-resistant Pseudomonas aeruginosa is declining in US academic medical centre hospitals. J Antimicrob Chemother (2012) 0.89

Nosocomial bloodstream infections in Brazilian pediatric patients: microbiology, epidemiology, and clinical features. PLoS One (2013) 0.88

Trends in aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in US academic medical centers: implications for antimicrobial stewardship. Infect Control Hosp Epidemiol (2012) 0.88

Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis (2010) 0.88

Influence of state laws mandating reporting of healthcare-associated infections: the case of central line-associated bloodstream infections. Infect Control Hosp Epidemiol (2013) 0.88

Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic. Am J Geriatr Pharmacother (2012) 0.87

Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections. J Clin Microbiol (2002) 0.87

Practices and an assessment of health care workers' perceptions of compliance with infection control knowledge of nosocomial infections. Am J Infect Control (2005) 0.87

Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit. Infect Control Hosp Epidemiol (2010) 0.87

Out-of-pocket costs and oral cancer medication discontinuation in the elderly. J Manag Care Spec Pharm (2014) 0.87

Controlled trial measuring the effect of a feedback intervention on hand hygiene compliance in a step-down unit. Infect Control Hosp Epidemiol (2008) 0.86

Surgeons do not listen: evaluation of compliance with antimicrobial stewardship program recommendations. Am Surg (2013) 0.85

Effect of contact precautions on wait time from emergency room disposition to inpatient admission. Infect Control Hosp Epidemiol (2011) 0.84

Targeted decolonization to prevent ICU infections. N Engl J Med (2013) 0.84

An active-learning laboratory on immunizations. Am J Pharm Educ (2012) 0.83

Beta-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates. Microb Drug Resist (2012) 0.83

Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres. J Antimicrob Chemother (2013) 0.83

The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control (2008) 0.82

Warfarin use in nursing home residents: results from the 2004 national nursing home survey. Am J Geriatr Pharmacother (2012) 0.82

Are gym surfaces reservoirs for Staphylococcus aureus? A point prevalence survey. Am J Infect Control (2012) 0.81

Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis. J Clin Microbiol (2006) 0.81

Preparing for 2009 H1N1 Influenza. N Engl J Med (2009) 0.81

Hand Hygiene: State-of-the-Art Review With Emphasis on New Technologies and Mechanisms of Surveillance. Curr Infect Dis Rep (2012) 0.81

Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection. BMC Infect Dis (2013) 0.80

Comparison of the systemic inflammatory response syndrome between monomicrobial and polymicrobial Pseudomonas aeruginosa nosocomial bloodstream infections. BMC Infect Dis (2005) 0.80

Improving the diagnosis of meningitis due to enterovirus and herpes simplex virus I and II in a tertiary care hospital. BMC Infect Dis (2013) 0.80

Listening to SARS: lessons for infection control. Ann Intern Med (2003) 0.80

Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients. J Am Geriatr Soc (2006) 0.79

Outcomes of patients with alcohol use disorders experiencing healthcare-associated infections. Alcohol Clin Exp Res (2011) 0.79

Positive Deviance: A New Tool for Infection Prevention and Patient Safety. Curr Infect Dis Rep (2013) 0.79

Lessons from severe acute respiratory syndrome (SARS): implications for infection control. Arch Med Res (2005) 0.78

Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter survey. Infect Control Hosp Epidemiol (2012) 0.78

Clinical outcomes of ambulatory acute exacerbations of chronic bronchitis with older versus newer antimicrobials. Ann Pharmacother (2002) 0.78

Testing for allergic disease: parameters considered and test value. BMC Fam Pract (2008) 0.78

Surgical site infection surveillance for neurosurgical procedures: a comparison of passive surveillance by surgeons to active surveillance by infection control professionals. Am J Infect Control (2007) 0.78

Preventing catheter-associated urinary tract infection in the zero-tolerance era. Am J Infect Control (2011) 0.77

Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study. Anemia (2012) 0.77

Secular trends in the epidemiology of Clostridium difficile infection (CDI): relationship with alcohol gel and antimicrobial usage in a hospital. Int J Infect Dis (2013) 0.77

Intracardiac juvenile xanthogranuloma with presentation in adulthood. Cardiovasc Pathol (2013) 0.76

Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database Syst Rev (2016) 0.76

Hand hygiene compliance in the critical care setting: a comparative study of 2 different alcohol handrub formulations. Am J Infect Control (2012) 0.76

Measuring hand hygiene compliance in a hematology-oncology unit: a comparative study of methodologies. Am J Infect Control (2013) 0.76

Can the antibiogram be used to assess microbiologic outcomes after antimicrobial stewardship interventions? A critical review of the literature. Pharmacotherapy (2012) 0.76

Positive deviance: using a nurse call system to evaluate hand hygiene practices. Am J Infect Control (2012) 0.76

An Epidemiological Study of Anemia and Renal Dysfunction in Patients Admitted to ICUs across the United States. Anemia (2012) 0.76